1. Functional Alignment Within the Fusion in Adult Spinal Deformity (ASD) Improves Outcomes and Minimizes Mechanical Failures.
- Author
-
Ani F, Ayres EW, Soroceanu A, Mundis GM, Smith JS, Gum JL, Daniels AH, Klineberg EO, Ames CP, Bess S, Shaffrey CI, Schwab FJ, Lafage V, and Protopsaltis TS
- Subjects
- Adult, Humans, Spine surgery, Retrospective Studies, Incidence, Postoperative Complications etiology, Kyphosis epidemiology, Spinal Fusion methods
- Abstract
Study Design: Retrospective review of an adult deformity database., Objective: To identify pelvic incidence (PI) and age-appropriate physical function alignment targets using a component angle of T1-pelvic angle within the fusion to define correction and their relationship to proximal junctional kyphosis (PJK) and clinical outcomes., Summary of Background Data: In preoperative planning, a patient's PI is often utilized to determine the alignment target. In a trend toward more patient-specific planning, age-specific alignment has been shown to reduce the risk of mechanical failures. PI and age have not been analyzed with respect to defining a functional alignment., Methods: A database of patients with operative adult spinal deformity was analyzed. Patients fused to the pelvis and upper-instrumented vertebrae above T11 were included. Alignment within the fusion correlated with clinical outcomes and PI. Short form 36-Physical Component Score (SF36-PCS) normative data and PI were used to compute functional alignment for each patient. Overcorrected, under-corrected, and functionally corrected groups were determined using T10-pelvic angle (T10PA)., Results: In all, 1052 patients met the inclusion criteria. T10PA correlated with SF36-PCS and PI (R=0.601). At six weeks, 40.7% were functionally corrected, 39.4% were overcorrected, and 20.9% were under-corrected. The PJK incidence rate was 13.6%. Overcorrected patients had the highest PJK rate (18.1%) compared with functionally (11.3%) and under-corrected (9.5%) patients ( P <0.05). Overcorrected patients had a trend toward more PJK revisions. All groups improved in HRQL; however, under-corrected patients had the worst 1-year SF36-PCS offset relative to normative patients of equivalent age (-8.1) versus functional (-6.1) and overcorrected (-4.5), P <0.05., Conclusions: T10PA was used to determine functional alignment, an alignment based on PI and age-appropriate physical function. Correcting patients to functional alignment produced improvements in clinical outcomes, with the lowest rates of PJK. This patient-specific approach to spinal alignment provides adult spinal deformity correction targets that can be used intraoperatively., Competing Interests: T.S.P.— Altus: IP royalties Globus; Medical: Paid consultant; Medtronic: Paid consultant; Nuvasive: Paid consultant. G.M.M.—Nuvasive: IP royalties: Paid consultant; Seaspine: IP royalties; Paid consultant; Stryker: IP royalties; Viseon: Paid consultant. J.S.S.—Carlsmed: Paid consultant; Cerapedics: Paid consultant; DePuy: Research support; Nuvasive: IP royalties; Paid consultant, Research support; Zimmer: IP royalties, Paid consultant. J.G.—Acuity: IP royalties, Paid consultant; Expanding Innovations: Paid consultant; Medtronic: Board or committee member, IP royalties, Paid consultant, Paid presenter, and Research support; Nuvasive: IP royalties and Paid consultant; Stryker: Paid consultant. A.H.D.—EOS: Paid consultant; Medtronic: IP royalties and Paid consultant; Orthofix, Inc.: Paid consultant and Research support; Spineart: IP royalties and Paid consultant. E.O.K.—AO: Paid consultant; DePuy: Paid consultant; Medtronic: Paid consultant; Stryker: Paid consultant. C.A.—Biomet Spine: IP royalties; DePuy: IP royalties, Paid consultant, and Research support; K2M: IP royalties and Paid consultant; Medicrea: IP royalties and Paid consultant; Next Orthosurgical: IP royalties; Nuvasive: IP royalties; Stryker: IP royalties. R.S.B.— allosource: Research support; Alphatec Spine: Paid consultant; K2 Medical: IP royalties and Paid consultant; Nuvasive: IP royalties and Research support; Stryker: IP royalties. C.I.S.—Globus Medical: Research support; Medtronic: IP royalties, Paid presenter or speaker, and Research support; Nuvasive: IP royalties, Paid consultant, Research support, and Stock or stock Options; Proprio: Paid consultant. F.J.S.—K2M: IP royalties; Mainstay Medical: Paid consultant; Medtronic: IP royalties; Nuvasive: Research support; See Spine LLC: Stock or stock Options; Zimmer: IP royalties and Paid consultant. V.L.—Alphatec Spine: Paid consultant; Globus Medical: Paid consultant; Nuvasive: IP royalties; Stryker: Paid presenter or speaker. The remaining authors report no conflicts of interest., (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF